Analysis of serum angiotensin-converting enzyme

Ann Clin Biochem 2002;39:436-443
doi:10.1258/000456302320314449
© 2002 Association for Clinical Biochemistry

 

This Article

Full Text (PDF)


Alert me when this article is cited

Alert me if a correction is posted
Services

Email this article to a friend

Similar articles in this journal


Similar articles in PubMed

Alert me to new issues of the journal

Download to citation manager

Citing Articles
Citing Articles via Google Scholar
Google Scholar

Articles by Muller, B.
Search for Related Content
PubMed

PubMed Citation
Social Bookmarking

What’s this?

Personal Views


BR Muller


Department of Clinical Chemistry, Charing Cross Hospital, Fulham Palace Road, London W6 8RF, UK

Serum angiotensin-converting enzyme (SACE) levels are influencedby genetic polymorphism. Interpretation of serum levels withthe appropriate genotypic reference range improves the diagnosticsensitivity of the assay for sarcoidosis. SACE assays are performedby a large number of routine clinical laboratories. However,there is no external quality assessment (EQA) for SACE otherthan an informal regional scheme. This showed analytical performanceof SACE assays to be poor, with a diversity of reference ranges,leading to widely disparate clinical classification of EQA samples.Genetic polymorphism combined with poor analytical performancesuggest that perhaps SACE assays should revert to being theprovince of specialized laboratories.

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What’s this?